Speaker illustration

Associate Professor Barak Zafrir

Lady Davis Carmel Medical Center, Haifa (Israel)

Member of:

European Society of Cardiology

Blood pressure response during treadmill exercise testing and the risk for future development of atrial fibrillation

Event: ESC Preventive Cardiology 2022

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters

Thumbnail

Coronary artery calcium and risk prediction in type 2 diabetics

Event: ESC Congress 2021 - The Digital Experience

Topic: Coronary Calcium

Session: Cardiac Computed Tomography ePosters

Thumbnail

A safety and clinical efficacy analysis of PCSK9 monoclonal antibodies in patients with markedly elevated creatine phosphokinase levels

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipid-Lowering Agents

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

Lymphopenia and risk for long-term mortality among patients undergoing coronary angiography

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease (Chronic) ePosters

Thumbnail

Long-term risk stratification of patients undergoing coronary angiography according to the TIMI risk score for secondary prevention

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Assessment of residual risk after percutaneous coronary intervention

Thumbnail

Clinical features and outcomes of severe and extreme hypertriglyceridemia in a regional health service

Event: ESC Congress 2018

Topic: Lipids

Session: Preventive cardiology / Lipids

Thumbnail

Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14,964 patients in the ESC heart failure long-term registry

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation in heart failure

Thumbnail

Impact of the presence and treatment status of diabetes on long-term mortality following coronary angiography

Event: ESC Congress 2016

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Improving diabetes outcomes: beyond glucocentricity

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb